In last trading session, Adaptive Biotechnologies Corp (NASDAQ:ADPT) saw 0.66 million shares changing hands with its beta currently measuring 1.48. Company’s recent per share price level of $5.85 trading at $0.12 or 2.09% at ring of the bell on the day assigns it a market valuation of $863.34M. That closing price of ADPT’s stock is at a discount of -14.53% from its 52-week high price of $6.70 and is indicating a premium of 61.03% from its 52-week low price of $2.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.79 million shares which gives us an average trading volume of 1.14 million if we extend that period to 3-months.
For Adaptive Biotechnologies Corp (ADPT), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 11 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
Upright in the green during last session for gaining 2.09%, in the last five days ADPT remained trading in the green while hitting it’s week-highest on Friday, 11/29/24 when the stock touched $5.85 price level, adding 2.5% to its value on the day. Adaptive Biotechnologies Corp’s shares saw a change of 19.39% in year-to-date performance and have moved 33.87% in past 5-day. Adaptive Biotechnologies Corp (NASDAQ:ADPT) showed a performance of 15.61% in past 30-days. Number of shares sold short was 8.2 million shares which calculate 7.86 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 58.21% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 18. It follows that stock’s current price would jump 14.53% in reaching the projected high whereas dropping to the targeted low would mean a gain of 14.53% for stock’s current value.
Adaptive Biotechnologies Corp (ADPT) estimates and forecasts
Statistics highlight that Adaptive Biotechnologies Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 69.57% of value to its shares in past 6 months, showing an annual growth rate of 18.84% while that of industry is 17.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 4.34% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 45.84M for the same. And 6 analysts are in estimates of company making revenue of 46.47M in the next quarter. Company posted 45.78M and 41.87M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -32.91% during past 5 years.
Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s Major holders
Insiders are in possession of 1.93% of company’s total shares while institution are holding 93.97 percent of that, with stock having share float percentage of 95.82%. Investors also watch the number of corporate investors in a company very closely, which is 93.97% institutions for Adaptive Biotechnologies Corp that are currently holding shares of the company. VIKING GLOBAL INVESTORS LP is the top institutional holder at ADPT for having 29.99 million shares of worth $108.58 million. And as of 2024-06-30, it was holding 20.5736 of the company’s outstanding shares.
The second largest institutional holder is RUBRIC CAPITAL MANAGEMENT LP, which was holding about 14.0 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.603 of outstanding shares, having a total worth of $50.68 million.
On the other hand, ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 11.26 shares of worth $66.86 million or 7.63% of the total outstanding shares. The later fund manager was in possession of 4.0 shares on Jun 30, 2024 , making its stake of worth around $23.73 million in the company or a holder of 2.71% of company’s stock.
